PAPER Lan Z, Chen L, Fu Q, Ji W, Wang S, Liang Z, Qu R, Kong L, Ma S
SEARCH RESULTS
329930 RESULTS
PAPER Lee KW, Im JY, Woo JM, Grosso H, Kim YS, Cristovao AC, Sonsalla PK, Schuster DS, Jalbut MM, Fernandez JR, Voronkov M, Junn E, Braithwaite SP, Stock JB, Mouradian MM
Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease.
Neurotherapeutics. 2013 Jan;10(1):143-53. PubMed: 23296837PAPER Sardi SP, Clarke J, Viel C, Chan M, Tamsett TJ, Treleaven CM, Bu J, Sweet L, Passini MA, Dodge JC, Yu WH, Sidman RL, Cheng SH, Shihabuddin LS
Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies.
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3537-42. PubMed: 23297226PAPER Lemaire N, Hernandez LF, Hu D, Kubota Y, Howe MW, Graybiel AM
Effects of dopamine depletion on LFP oscillations in striatum are task- and learning-dependent and selectively reversed by L-DOPA.
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18126-31. PubMed: 23074253PAPER Chen D, Pang S, Feng X, Huang W, Hawley RG, Yan B
Genetic analysis of the ATG7 gene promoter in sporadic Parkinson's disease.
Neurosci Lett. 2013 Feb 8;534:193-8. PubMed: 23295909PAPER Biju KC, Santacruz RA, Chen C, Zhou Q, Yao J, Rohrabaugh SL, Clark RA, Roberts JL, Phillips KA, Imam SZ, Li S
Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Neurosci Lett. 2013 Feb 22;535:24-9. PubMed: 23295906PAPER Kingwell K
Parkinson disease: Overcoming hurdles to stem-cell transplantation for treatment of Parkinson disease.
Nat Rev Neurol. 2013 Feb;9(2):60. PubMed: 23296340PAPER Dardiotis E, Xiromerisiou G, Hadjichristodoulou C, Tsatsakis AM, Wilks MF, Hadjigeorgiou GM
The interplay between environmental and genetic factors in Parkinson's disease susceptibility: The evidence for pesticides.
Toxicology. 2013 Jan 4; PubMed: 23295711PAPER Gräff J, Tsai LH
The potential of HDAC inhibitors as cognitive enhancers.
Annu Rev Pharmacol Toxicol. 2013;53:311-30. PubMed: 23294310PAPER Peuchmaur M, Lacour MA, Sévalle J, Lisowski V, Touati-Jallabe Y, Rodier F, Martinez J, Checler F, Hernandez JF
Further characterization of a putative serine protease contributing to the γ-secretase cleavage of β-amyloid precursor protein.
Bioorg Med Chem. 2013 Feb 15;21(4):1018-29. PubMed: 23294826PAPER Matsubara T, Iijima K, Yamamoto N, Yanagisawa K, Sato T
Density of GM1 in nanoclusters is a critical factor in the formation of a spherical assembly of amyloid β-protein on synaptic plasma membranes.
Langmuir. 2013 Feb 19;29(7):2258-64. PubMed: 23294326PAPER Tycko R, Wickner RB
Molecular structures of amyloid and prion fibrils: consensus versus controversy.
Acc Chem Res. 2013 Jul 16;46(7):1487-96. Epub 2013 Jan 7 PubMed: 23294335PAPER Vallet GT, Hudon C, Simard M, Versace R
The disconnection syndrome in the Alzheimer's disease: The cross-modal priming example.
Cortex. 2012 Dec 5; PubMed: 23294572PAPER Reid AT, Evans AC
Structural networks in Alzheimer's disease.
Eur Neuropsychopharmacol. 2013 Jan;23(1):63-77. PubMed: 23294972PAPER Ferguson SA, Sarkar S, Schmued LC
Longitudinal behavioral changes in the APP/PS1 transgenic Alzheimer's disease model.
Behav Brain Res. 2013 Apr 1;242:125-34. PubMed: 23295401Current Filters
No filters selected